NCT06792864View on ClinicalTrials.gov

Effectiveness of 3D Bone Matrix in Cranioplasty

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

December 1, 2025

Conditions
CranioplastyCraniotomyCraniotomy ClippingCraniotomy SurgeryCraniocerebral TraumaCraniocerebral Injuries
Interventions
DEVICE

OsteoprintCR

Hybrid technique of 3D printed bone matrix based on polycaprolactone with tricalcium beta phosphate

DEVICE

SMAR SET GMV Endurance Gentamicin

"Patient undergoing cranioplasty with conventional technique using polymethylmethylmethacrylate-based surgical cement brand SMAR SET GMV Endurance Gentamicin."

Trial Locations (1)

5110434

Hospital Base de Valdivia, Valdivia

All Listed Sponsors
lead

Universidad Austral de Chile

OTHER